Evidence map›Paper›PMID 42317116›Full record

ArticleEuropean journal of breast health2026

Bilateral Myeloid Sarcoma of Breast: A Case Report and Discussion.

Lian Li, Zhi Liu, Huiling Zhang, Yudie Zou, Yingjia Li

Abstract read
In one paragraph

Article in European journal of breast health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lian LiDepartment of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.ORCID 0009-0000-9631-209X
Zhi LiuDepartment of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Huiling ZhangDepartment of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Yudie ZouDepartment of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.ORCID 0009-0001-2224-0860
Yingjia LiDepartment of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.ORCID 0000-0003-0540-5667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcoma (MS) involving the breast is rare. We reviewed a case of a 21-year-old female with palpable masses in the bilateral breasts without medullary acute myeloid leukemia. Ultrasound revealed irregular, indistinct, and complex hypoechoic masses with internal blood flow and hyperechoic halos in the bilateral breasts. A biopsy was subsequently recommended, and MS was confirmed. Further cytogenetic evaluation of breast biopsy specimens demonstrated positive t(16;16)(p13.1;q22) translocation. The patient was admitted for chemotherapy. Subsequent follow-up breast ultrasound following chemotherapy revealed a notable treatment response. This report aims to delineate the ultrasound characteristics of breast MS and the utilization of ultrasound in the evaluation of early response to chemotherapy.

Indexed as

breastMyeloid sarcomaultrasonography

Identifiers

PMID42317116
PMCPMC13280594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.